Form 4 for CORT CORCEPT THERAPEUTICS INC
Accepted 2022-12-05 00:00:00 ET · period of report 2022-12-01 · accession 0000899243-22-037636 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-12-05 | 2022-12-01 | CORT | Maduck Sean | See Remarks | M - OptEx | $3.29 | +625 | 57.1K | +1% | +$2,056 |
| D | 2022-12-05 | 2022-12-01 | CORT | Maduck Sean | See Remarks | S - Sale+OE | $25.28 | -625 | 56.5K | -1% | -$15.8K |
| D | 2022-12-05 | 2022-12-01 | CORT | Maduck Sean | See Remarks | M - OptEx | $0.00 | -625 | 32.0K | -2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-01 | M | A | 625 | $3.29 | 57,087 | D | — | — | (F2) Includes 922 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2022. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. |
| 2 | Common | Common Stock | 2022-12-01 | S | D | 625 | $25.28 | 56,462 | D | — | — | (F2) Includes 922 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2022. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. |
| 3 | Derivative | Stock option (right to buy) | 2022-12-01 | M | D | 625 | $0.00 | 31,977 | D | $3.29 · — to 2025-02-18 | 625 Common Stock | (F5) Fully exercisable. |